1.

PHP115 THE INCORPORATION OF ECONOMIC EVIDENCE IN THE DUTCH CLINICAL PRACTICE GUIDELINES

1.

PSS9 The Burden of Age-related Macular Degeneration in the Netherlands

1.

Societal consequences of migraine in The Netherlands (in Dutch)

2.

Societal consequences of migraine in The Netherlands (in Dutch)

3.

Societal consequences of migraine in The Netherlands (in Dutch)

1.

Manual Health and Labour Questionnaire (in Dutch)

1.

Orphan drugs expenditure in the Netherlands in the period 2006-2012

1.

Costs of Alzheimer's disease (in Dutch); A study of the most important cost items of patients with Alzheimer's disease in the Netherlands and in France

2.

Costs of Alzheimer's disease (in Dutch); A study of the most important cost items of patients with Alzheimer's disease in the Netherlands and in France

3.

Costs of Alzheimer's disease (in Dutch); A study of the most important cost items of patients with Alzheimer's disease in the Netherlands and in France

1.

PMH34 TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): ESTIMATING THE MAXIMUM ALLOWABLE COST OF PSYCHOSOCIAL INTERVENTIONS IN THE UNITED STATES, GERMANY. THE NETHERLAN...

1.

Patient, family and productivity costs of endstage renal disease in the Netherlands:exposing non-healthcare related costs

2.

Patient, family and productivity costs of endstage renal disease in the Netherlands:exposing non-healthcare related costs

3.

Patient, family and productivity costs of endstage renal disease in the Netherlands:exposing non-healthcare related costs

1.

Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands

1.

Burden of illness of hip fractures in elderly Dutch patients

2.

Burden of illness of hip fractures in elderly Dutch patients

3.

Burden of illness of hip fractures in elderly Dutch patients